Amicus Therapeutics Inc (FOLD)

Apr 27, 2025

Amicus Therapeutics (FOLD) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Apr 27, 2025

Apr 27, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 27, 2025

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

Rock Springs Capital Management LP Purchases 1,349,145 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 26, 2025

Apr 24, 2025

Jump Financial LLC Lowers Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 24, 2025

Apr 24, 2025

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Apr 24, 2025

Apr 23, 2025

Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Amicus Therapeutics to Report Q1 Earnings: What's in the Cards? - Yahoo Finance

Apr 23, 2025

Apr 22, 2025

11 Best Guru Stocks to Buy According to Wall Street Analysts - Insider Monkey

Apr 22, 2025

Apr 21, 2025

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 | FOLD Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewswire

Apr 21, 2025

Apr 21, 2025

Pompe Disease Therapeutic Market Projected To Witness - openPR.com

Apr 21, 2025

Apr 18, 2025

Granite Investment Partners LLC Purchases 166,657 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Renaissance Technologies LLC Has $19.86 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 18, 2025

Apr 17, 2025

4 Healthcare Stocks to Buy as the Sector Faces Government Heat - Yahoo Finance

Apr 17, 2025

Apr 16, 2025

(FOLD) Proactive Strategies - news.stocktradersdaily.com

Apr 16, 2025

Apr 14, 2025

Pompe Disease Treatment Market New Product Development & Latest Trends | Sanofi,Amicus Therapeutics,Genzym - openPR.com

Apr 14, 2025

Apr 14, 2025

Enzyme Replacement Therapy Market Is Booming Worldwide - openPR.com

Apr 14, 2025

Apr 14, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Down 6.3%Should You Sell? - MarketBeat

Apr 14, 2025

Apr 12, 2025

Amicus Therapeutics (NASDAQ:FOLD) Sets New 52-Week LowHere's What Happened - MarketBeat

Apr 12, 2025

Apr 11, 2025

Norges Bank Invests $29.03 Million in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 11, 2025

Apr 11, 2025

Is ​​Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In? - Insider Monkey

Apr 11, 2025

Apr 11, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st

Apr 11, 2025

Apr 11, 2025

ExodusPoint Capital Management LP Trims Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 11, 2025

Apr 11, 2025

Massachusetts Financial Services Co. MA Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 11, 2025

Apr 10, 2025

Fabry Disease Treatment Market Opportunity and Forecast Report 2025-2034 Featuring Amicus Therapeutics, Avrobio, Freeline, Idorsia, ISU Abxis, JCR, Novartis, Pfizer, Protalix, Sanofi, Takeda, Viatris - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon - Yahoo Finance

Apr 10, 2025

Apr 09, 2025

Vanguard Group Inc. Has $275.62 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 09, 2025

Apr 08, 2025

JPMorgan Chase & Co. Reduces Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 08, 2025

Apr 08, 2025

Amicus Therapeutics stock hits 52-week low at $6.99 By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

Amicus Therapeutics stock hits 52-week low at $6.99 - Investing.com

Apr 08, 2025

Apr 08, 2025

Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires? - Insider Monkey

Apr 08, 2025

Apr 08, 2025

What is Zacks Research's Estimate for FOLD Q1 Earnings? - MarketBeat

Apr 08, 2025

Apr 07, 2025

Trexquant Investment LP Acquires 486,827 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 07, 2025

Apr 07, 2025

AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. - Bluefield Daily Telegraph

Apr 07, 2025

Apr 07, 2025

AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire

Apr 07, 2025

Apr 07, 2025

Old West Investment Management LLC Raises Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 07, 2025

Apr 07, 2025

Zacks Research Analysts Increase Earnings Estimates for FOLD - MarketBeat

Apr 07, 2025

Apr 07, 2025

Pictet Asset Management Holding SA Sells 110,241 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 07, 2025